Q3 EARNINGS: Abbott's devices a drag; Boston beats on revenues
This article was originally published in Clinica
Executive Summary
Abbott’s medical devices franchise was its worst-performing business, with sales falling 1%; but this did not dent the firm’s overall third-quarter results which fell in-line with expectations. Group Q3 revenues of $5.1bn from continuing operations were up 6% year-on-year; while revenues from both continuing and discontinued operations of $5.6bn met analyst predictions.